Glioblastoma
3 481 new cases in France in 2018 (estimate, histologically confirmed glioblastomas) 1
What is it?
Glioblastoma is a tumor that starts in the brain, arising from astrocytes, the supporting cells of the nervous system. It is a grade 4 tumor according to the WHO classification 2.
How it develops
It infiltrates nearby brain tissue, making complete removal difficult. However, it very rarely spreads outside the brain 2.
How long does it take to develop?
The first genetic abnormalities may appear about 2 to 7 years before the tumor is found, after which a mutation may trigger rapid growth 3. Symptoms typically develop over a few days to a few weeks.
Risk factors
- Exposure to high doses of ionizing radiation (previous radiotherapy), the only well-established factor
- Age and male sex
- Rare hereditary syndromes (Li-Fraumeni, neurofibromatosis)
Signs that should prompt a visit to your doctor
In the early stages
- Glioblastoma: it may cause no signs at first
As it grows
- Unusual headaches, especially in the morning, with nausea or vomiting
- A seizure
- Depending on the area: problems with speech, vision or memory, weakness on one side of the body
Good to know
- It does not spread to other organs
- Signs depend mainly on the area affected
These symptoms do not necessarily mean glioblastoma. An unusual headache that persists? Talk to your doctor.
⁴New headaches that are worse in the morning, an unusual seizure, weakness on one side of the body, problems with speech, vision, behavior or memory. These signs warrant prompt medical advice; they often have another cause 5.
Detected early or at a later stage
The concept of stage (localized, regional, distant) does not apply to glioblastoma. Prognosis depends on its molecular characteristics, age and how much of the tumor can be removed 2.
5-year survival by stage
France: age-standardized 5-year net survival 1; United States: 5-year survival 6. In France, 1-year net survival improved by 21 percentage points between 1990 and 2015 1. To date, no study has shown that earlier detection improves survival: research continues.
Screening in France
No, there is no organized or recommended cancer screening.
Monitoring for people at risk
People with a hereditary syndrome receive specialist genetic follow-up 2.

Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →Frequently asked questions
Do I need a prescription?
No. With Prevonco, you do not need a prescription: after ordering online, a unique code gives you access to the test at one of our partner laboratories. In France, some laboratory tests can be carried out at your request, without a prescription.
No prescription, but still a doctor: they remain central to the process. Your result is sent to the doctor you selected from our panel, who will explain it during a 30-minute video consultation, included whatever the result.
Are you receiving care for cancer? Speak directly to your oncologist: they can prescribe this test without going through Prevonco.
For any questions about your situation, or if you have symptoms, your doctor remains your first point of contact.
What if my level is high?
A high level tends to be a strong signal. It is not a conclusion: its cause needs to be investigated with a doctor.⁷
Your result is sent to the doctor you selected from our panel. They will explain it during the 30-minute video consultation included in the price. Further investigations prescribed by a doctor can help identify the cause.⁷
What if the level is intermediate? It may not be related to cancer (smoking, an inflammatory condition, etc.). Other blood tests may be suggested; if they are normal, a repeat check is planned at 12 months. You will never be left to face your result alone.⁷
What if my level is low?
That is reassuring, but no test is perfect: a low level does not rule everything out.⁷
If you have no symptoms, no specific follow-up is recommended after a low result. The risk of a false negative varies by cancer type.⁷
Your doctor, who is trained in functional medicine and specialises in prevention, will help you explore any concerns or symptoms during the 30-minute video consultation.⁷
Keep up with your usual screening: respond to invitations for organised screening programmes, and see your doctor if a symptom appears.⁷
How long will it take to get my results?
The laboratory analysis takes 30 days. Your full results are presented by a doctor trained in functional medicine during a 30-minute consultation included in your package.
You choose the date and time slot that suit you for this appointment.
Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →General information for educational purposes: it does not replace your doctor's advice. An aid to early detection: it does not replace organised screening, imaging tests or your doctor's advice.
Sources
- 1.Santé publique France, Survie des personnes atteintes de cancer en France métropolitaine 1989-2018 – Système nerveux central – Glioblastomes
- 2.StatPearls (NCBI), Glioblastoma Multiforme
- 3.Körber et al., Cancer Cell, 2019
- 4.INCa (cancer.fr, 03/06/2015)
- 5.Mayo Clinic, glioblastoma – symptoms and causes
- 6.NAACCR / CBTRUS, Glioblastoma brain tumors
- 7.biodena.care